0001709913-21-000001.txt : 20210104 0001709913-21-000001.hdr.sgml : 20210104 20210104110759 ACCESSION NUMBER: 0001709913-21-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210104 DATE AS OF CHANGE: 20210104 EFFECTIVENESS DATE: 20210104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kryo, Inc. CENTRAL INDEX KEY: 0001709913 IRS NUMBER: 813741967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-384171 FILM NUMBER: 21500598 BUSINESS ADDRESS: STREET 1: 144 TALBERT POINTE DR., SUITE 103 CITY: MOORESVILLE STATE: NC ZIP: 28117 BUSINESS PHONE: 877-235-6271 MAIL ADDRESS: STREET 1: 144 TALBERT POINTE DR., SUITE 103 CITY: MOORESVILLE STATE: NC ZIP: 28117 D/A 1 primary_doc.xml X0708 D/A LIVE 0001709913 Kryo, Inc. 144 TALBERT POINTE DR., SUITE 103 MOORESVILLE NC NORTH CAROLINA 28117 877-235-6271 DELAWARE Kryo, LLC None Corporation true 2016 Todd Youngblood c/o Kryo, Inc. 144 Talbert Pointe Dr., Suite 103 Mooresville NC NORTH CAROLINA 28117 Executive Officer Director Tara Youngblood c/o Kryo, Inc. 144 Talbert Pointe Dr., Suite 103 Mooresville NC NORTH CAROLINA 28117 Executive Officer Director Sulekha Ramayya c/o Kryo, Inc. 144 Talbert Pointe Dr., Suite 103 Mooresville NC NORTH CAROLINA 28117 Director Other Technology Decline to Disclose 06b true 0001709913-20-000002 2020-12-09 false true true In connection with the acquisition of Ebb Therapeutics, Inc. by Kryo, Inc. (the "Company"), the Company entered into a stock purchase agreement providing for the issuance of the Company's preferred stock to an accredited investor. 0 Charles Towne Securities, LLC 172278 Charles Towne Securities, LLC 172278 701 E Bay Street Suite 405 Charleston SC SOUTH CAROLINA 29403 All States false 20000000 20000000 0 false 1 868000 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false Kryo, Inc. /s/ Tara Youngblood Tara Youngblood Chief Executive Officer 2021-01-04